A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15C SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol
Latest Information Update: 05 Jan 2024
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacokinetics; Registrational
- Sponsors United Therapeutics Corporation
- 25 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2014 New trial record